Vera Therapeutics, Inc. (VERA) Operating income 2020–2025
Vera Therapeutics, Inc. (VERA) annual operating income history from SEC filings — each fiscal year as reported.
-$315.5MFY2025 · since FY2020: -$52.2M → -$315.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$315.5M | -88.7% |
| FY2024 | -$167.2M | -63.9% |
| FY2023 | -$102.0M | -12.2% |
| FY2022 | -$90.9M | -164.2% |
| FY2021 | -$34.4M | +34.1% |
| FY2020 | -$52.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VERA financial trends
VERA RevenueVERA Net incomeVERA Net marginVERA Gross profitVERA Gross marginVERA Operating marginVERA Operating cash flowVERA Free cash flowVERA Capital expendituresVERA Return on equityVERA Stock buybacksVERA Dividends paidVERA Total assetsVERA Total liabilitiesVERA Shareholders’ equityVERA overview →